Discontinuation of CT in nonfunctioning incidentaloma
Would you recommend discontinuation of regular computed tomography scans in a patient with a nonfunctioning incidentaloma and no tumor growth over 3- or 5-year follow-up?
Would you recommend discontinuation of regular computed tomography scans in a patient with a nonfunctioning incidentaloma and no tumor growth over 3- or 5-year follow-up?
How often and for how long should computed tomography be repeated in the follow-up of a nonfunctioning adrenal incidentaloma?
How often should hormonal laboratory tests be repeated in the follow-up of a patient with an initially nonfunctioning adrenal incidentaloma?
Should every patient with an incidentally discovered adrenal mass be evaluated for pheochromocytoma and hyperaldosteronism even in the absence of hypertension?
What should be the target hemoglobin A1c (HbA1c) values in patients with type 2 diabetes mellitus?
Should every pregnant woman with thyroid-stimulating hormone [TSH] levels >2.5 mIU/L be treated with levothyroxine even in the absence of anti-thyroid peroxidase antibodies and antithyroglobulin antibodies?
Do thyroid-stimulating hormone (TSH) levels change with age? Should we use different criteria to diagnose and treat hypothyroidism in the elderly?
Does an isolated measurement of a thyroid-stimulating hormone (TSH) level >2.5 mIU/L in a premenopausal woman warrant treatment? Should the measurement be repeated or supplemented by other tests?
Is it recommended to take wound swabs in patients with the diabetic foot and use antibiotics based on susceptibility testing?
Should metformin remain the first-line therapy in type 2 diabetes mellitus?